Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Cytochrome P450 2C19*2 polymorphism in patients with stable coronary heart disease and risk for secondary cardiovascular disease events: results of a long-term follow-up study in routine clinical care - art. no. 61

Rothenbacher, D and Hoffmann, MM and Breitling, LP and Rajman, I and Koenig, W and Brenner, H (2013) Cytochrome P450 2C19*2 polymorphism in patients with stable coronary heart disease and risk for secondary cardiovascular disease events: results of a long-term follow-up study in routine clinical care - art. no. 61. BMC CARDIOVASCULAR DISORDERS. 61-.

Item Type: Article
Additional Information: pubid: 59 nvp_institute: NIBR contributor_address: Univ Ulm, Inst Epidemiol & Med Biometry, D-89081 Ulm, Germany, German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany dietrich.rothenbacher@uni-ulm.de; Univ Med Ctr Freiburg, Dept Clin Chem, Freiburg, Germany ; German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany ; Novartis Inst Biomed Res, Basel, Switzerland ; Univ Ulm, Dept Internal Med Cardiol 2, Med Ctr, D-89069 Ulm, Germany ; Univ Ulm, Inst Epidemiol & Med Biometry, D-89081 Ulm, Germany; German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; Rothenbacher, D; Univ Ulm, Inst Epidemiol & Med Biometry, Helmholtzstr 22, D-89081 Ulm, Germany
Date Deposited: 13 Oct 2015 13:13
Last Modified: 13 Oct 2015 13:13
URI: https://oak.novartis.com/id/eprint/21906

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.